未登录

R

Rosamund Chapman

University of Cape Town

H指数:18

被引数:920

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of modification of envelope proteins on the mechanical properties of HIV virus-like particles

修饰包膜蛋白对HIV病毒样颗粒力学性质的影响

Journal of the Mechanical Behavior of Biomedical Materials

IF3.5

2026-03-100

OAAI

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

IF3.5

2025-02-170

OAAI

Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies

IF3.4

2024-09-181

OAAI

LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters

IF3.5

2023-06-214

OAAI

Lumpy Skin Disease-An Emerging Cattle Disease in Europe and Asia

IF3.4

2023-03-0221

OAAI

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines

IF3.4

2023-02-071

OAAI

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector

IF3.4

2021-10-049

OAAI

Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana

FRONTIERS IN PLANT SCIENCE

IF4.8

2021-07-2212

OAAI

Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages

IF3.5

2021-03-022

OAAI

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa

NATURE REVIEWS MICROBIOLOGY

IF103.3

2020-09-1040

OAAI

Phylogenetic Analysis of South African Bovine Leukaemia Virus (BLV) Isolates

IF3.5

2020-08-175

OAAI

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles

IF3.4

2020-01-2915

OAAI

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens

FRONTIERS IN PLANT SCIENCE

IF4.8

2019-10-3026

OAAI

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation

新型增强型DNA疫苗载体在临床前病毒疫苗研究中的应用

IF3.4

2019-06-1313

OAAI

Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus

JOURNAL OF VIROLOGY

IF3.8

2019-04-1535

OAAI

Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model

JOURNAL OF VIROLOGY

IF3.8

2013-05-0125

OAAI